>>> US Research Calls I

Research Calls I
  • Upgrades:
    • Alector (ALEC) upgraded to Overweight from Neutral at Cantor Fitzgerald
    • American Tower (AMT) upgraded to Outperform from Neutral at Mizuho, tgt $205
    • Atlas Energy Solutions (AESI) upgraded to Buy from Neutral at Citigroup; tgt $18
    • Cloudflare (NET) upgraded to Overweight from Neutral at Piper Sandler, tgt $222
    • CRH (CRH) upgraded to Overweight from Equal Weight at Wells Fargo, tgt $135
    • ProPetro (PUMP) upgraded to Buy from Neutral at Citigroup; tgt $16
    • Symbotic (SYM) upgraded to Buy from Neutral at DA Davidson, tgt $70
  • Downgrades:
    • Adecoagro (AGRO) downgraded to Neutral from Buy at Citigroup, tgt $15
    • Autoliv (ALV) downgraded to Hold from Buy at Jefferies, tgt $120
    • BRP Inc. (DOO) downgraded to Hold from Buy at TD Cowen
    • Energy Recovery (ERII) downgraded to Neutral from Buy at Northcoast
    • Immunic (IMUX) downgraded to Hold from Buy at D. Boral Capital
    • Integra LifeSciences (IART) downgraded to Hold from Buy at Argus
    • Janux Therapeutics (JANX) downgraded to Neutral from Buy at UBS, tgt $15
    • Parsons (PSN) downgraded to Sector Weight from Overweight at KeyBanc
    • Public Service Enterprise Group (PEG) downgraded to Hold from Buy at Jefferies, tgt $89
    • Shift4 Payments (FOUR) downgraded to Peer Perform from Outperform at Wolfe Research
    • SolarEdge Technologies (SEDG) downgraded to Sell from Neutral at Goldman, tgt $31
  • Others:
    • Align Technology (ALGN) initiated with a Buy at Citigroup, tgt $240
    • Autodesk (ADSK) initiated with a Buy at Jefferies, tgt $300
    • Chime (CHYM) initiated with a Buy at Texas Capital, tgt $28
    • Climb Bio (CLYM) initiated with an Outperform at Mizuho, tgt $18
    • Dentsply Sirona (XRAY) initiated with a Sell at Citigroup, tgt $10
    • Eagle Bancorp (EGBN) initiated with a Strong Buy at Raymond James, tgt $32
    • Elanco Animal Health (ELAN) initiated with a Buy at Citigroup, tgt $30
    • Elicio Therapeutics (ELTX) initiated with a Buy at Ladenburg, tgt $20
    • Envista (NVST) initiated with a Neutral at Citigroup, tgt $29
    • Evotec (EVO) assumed with a Buy at H.C. Wainwright, tgt $7
    • Henry Schein (HSIC) initiated with a Buy at Citigroup, tgt $100
    • IDEXX Laboratories (IDXX) initiated with a Neutral at Citigroup, tgt $650
    • John Marshall Bancorp (JMSB) initiated with a Strong Buy at Raymond James, tgt $24
    • Kazia Therapeutics (KZIA) initiated with a Buy at Laidlaw, tgt $25
    • Minerva Neurosciences (NERV) initiated with an Outperform at Citizens, tgt $14
    • Navan (NAVN) initiated with a Buy at TD Cowen, tgt $18
    • NervGen Pharma (NGEN) initiated with a Buy at Lucid Capital, tgt $18
    • OBOOK Holdings (OWLS) initiated with a Buy at Benchmark, tgt $11
    • Phibro Animal Health (PAHC) initiated with a Neutral at Citigroup, tgt $62
    • Royal Gold (RGLD) initiated with a Buy at UBS, tgt $325
    • SoFi Technologies (SOFI) initiated with a Hold at Argus
    • Southside Bancshares (SBSI) assumed with a Neutral at Piper Sandler, tgt $35
    • Tyra Biosciences (TYRA) initiated with a Buy at Guggenheim, tgt $54
    • XBP Global (XBP) initiated with an Overweight at Cantor Fitzgerald, tgt $5
    • Zoetis (ZTS) initiated with a Buy at Citigroup, tgt $145